Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions
Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Returns by 2028
Micron on Track for Best Monthly Rally Since 1987 Analysts Suggest Further Upside Potential
White House and China Announce Trade Deals on Soybeans and Rare Earths Following TrumpXi Summit
Consumer Credit Growth Surges in December Amid Holiday Spending
JK Cement Posts 13 Volume Growth in Q4FY26 Outpacing Industry Amid Rising Cost Pressures
Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher
VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Beat
Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances
Guidewire Q1 2026 Earnings EPS Surges Past Estimates by 484 as Operating Performance Strengthens
MRTN Q1 2026 Earnings EPS Beats Estimates by 1765 Shares Edge Higher
AMSC Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism
Everus Construction Group ECG Holds Steady Near Key Support After Modest Decline
Brookfield Renewable Partners BEP Edges Higher as It Holds Above Key Support
Bassett Furniture BSET Holds Steady Near Resistance as Volume Signals Caution
ONEOK Inc OKE Holds Steady Near Support Level Amid Modest Pullback
Phio Pharmaceuticals PHIO Holds Ground Modest Gain Amid Key Technical Levels
Ready Capital Corporation 620 Senior Notes due 2026 RCB Q1 2026 Earnings Significant EPS Miss Highlights Challenges
Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure
Autohome Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Dips
Tiptree Inc TIPT Q2 2025 Earnings Solid EPS Performance Despite Revenue Opacity
SO Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher
USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh
Marvell United Airlines and Zscaler Lead Market Movers as Investors Assess Sector Trends
PEW Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress
Artelo Biosciences ARTL Gains 735 Biotech Stock Tests Resistance Near 153